India Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others
Summary
GlobalData’s “India Oncology Market Outlook to 2033” is a comprehensive databook report, covering key market data on the India Oncology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests, HER2 Tests, BRCA Tests, ALK Tests, BRAF Tests, BCR-ABL Tests and PD-L1 Tests
The India Oncology Market report provides key information and data on -
- Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
- 2024 company share data for Oncology Market.
- Global corporate-level profiles of key companies operating within the India Oncology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
India Oncology is segmented as follows -
- Colorectal Cancer Screening Tests
- EGFR Tests
- KRAS Tests
- HER2 Tests
- BRCA Tests
- ALK Tests
- BRAF Tests
- BCR-ABL Tests
- PD-L1 Tests
The India Oncology Market report helps you to develop -
- Business strategies by identifying the key market segments poised for strong growth in the future.
- Market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
- 1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
- 2 Introduction
- 2.1 What Is This Report About?
- 2.2 Oncology Market Segmentation
- 2.3 Definitions of Markets Covered in the Report
- 3 Oncology Market, India
- 3.1 Oncology Market, India, Revenue ($m), 2018-2033
- 3.1.1 ALK Tests Market, India, Revenue ($m), by Segment, 2018-2033
- 3.1.2 BCR-ABL Tests Market, India, Revenue ($m), by Segment, 2018-2033
- 3.1.3 BRAF Tests Market, India, Revenue ($m), by Segment, 2018-2033
- 3.1.4 BRCA Tests Market, India, Revenue ($m), by Segment, 2018-2033
- 3.1.5 Colorectal Cancer Screening Tests Market, India, Revenue ($m), by Segment, 2018-2033
- 3.1.6 EGFR Tests Market, India, Revenue ($m), by Segment, 2018-2033
- 3.1.7 HER2 Tests Market, India, Revenue ($m), by Segment, 2018-2033
- 3.1.8 KRAS Tests Market, India, Revenue ($m), by Segment, 2018-2033
- 3.2 Oncology Market, India, Volume (Units), 2018-2033
- 3.2.1 ALK Tests Market, India, Volume (Units), by Segment, 2018-2033
- 3.2.2 BCR-ABL Tests Market, India, Volume (Units), by Segment, 2018-2033
- 3.2.3 BRAF Tests Market, India, Volume (Units), by Segment, 2018-2033
- 3.2.4 BRCA Tests Market, India, Volume (Units), by Segment, 2018-2033
- 3.2.5 Colorectal Cancer Screening Tests Market, India, Volume (Units), by Segment, 2018-2033
- 3.2.6 EGFR Tests Market, India, Volume (Units), by Segment, 2018-2033
- 3.2.7 HER2 Tests Market, India, Volume (Units), by Segment, 2018-2033
- 3.2.8 KRAS Tests Market, India, Volume (Units), by Segment, 2018-2033
- 3.3 Oncology Market, India, Average Price ($) , 2018-2033
- 3.4 Oncology Market, India, Company Share by Revenue ($m), 2024
- 4 Overview of Key Companies in India, Oncology Market
- 4.1 F. Hoffmann-La Roche Ltd
- 4.1.1 Company Overview
- 4.2 BioGenex Laboratories Inc
- 4.2.1 Company Overview
- 4.3 Agilent Technologies Inc
- 4.3.1 Company Overview
- 4.4 Danaher Corp
- 4.4.1 Company Overview
- 4.5 Eiken Chemical Co Ltd
- 4.5.1 Company Overview
- 4.6 Hemosure Inc
- 4.6.1 Company Overview
- 4.7 Quidelortho Corp
- 4.7.1 Company Overview
- 4.8 Qiagen NV
- 4.8.1 Company Overview
- 4.9 Bio-Techne Corp
- 4.9.1 Company Overview
- 5 Oncology Market Pipeline Products
- 6 Financial Deals Landscape
- 6.1 Venture Financing
- 6.1.1 Oncare Secures USD1 Million in Seed Funding
- 6.1.2 Cambrian Bioworks Secures USD1.45 Million in Seed Financing
- 6.1.3 4baseCare Raises USD5.95 Million in Series A Funding
- 7 Recent Developments
- 7.1 Other Significant Developments
- 7.1.1 Sep 11, 2024: Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Awardees, Including First Recipients in India and the Netherlands
- 7.1.2 Jul 25, 2024: Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results
- 7.2 Product News
- 7.2.1 Jan 28, 2025: Datar Cancer Genetics To Provide Groundbreaking Video-Enhanced Results of In-Vitro Chemotherapy Effectiveness Tests for Cancer Patients
- 7.2.2 Jan 23, 2025: Guardant Health To Present Data at ASCO GI Demonstrating the Value of Its Precision Oncology Tools for Cancer Detection, Treatment Decisions and Therapy Development
- 7.2.3 Jul 30, 2024: Biocon Foundation and IISc organize OCTF Conference on Artificial Intelligence in Oral Cancer
- 7.2.4 Jul 15, 2024: Peptomyc S.L. Expands Patent Portfolio with European and Indian Patent Grant for its Methods and Composition for the Treatment of Cancer
- 7.3 Strategy And Business Planning
- 7.3.1 Oct 29, 2024: American Oncology Network (AON) and Vantage Health Technologies Partner to Improve Cancer Patient Outcomes with AI-enabled Value-Based Care Platform
- 7.3.2 Jul 01, 2024: NURA Health Screening Center Opens in Hanoi, Vietnam
- 8 Appendix
- 8.1 Research Methodology
- 8.1.1 Coverage
- 8.1.2 Secondary Research
- 8.1.3 Primary Research
- 8.1.4 Market Modeling and Forecasting
- 8.1.5 Company Share Analysis
- 8.1.6 Benchmarking
- 8.2 GlobalData Consulting
- 8.3 Contact Us
- 8.4 Disclaimer
- List of Tables
- Table 1: Oncology Market, India, Revenue ($m), USD Constant, 2018-2033
- Table 2: ALK Tests Market, India, Revenue ($m), USD Constant, 2018-2033
- Table 3: BCR-ABL Tests Market, India, Revenue ($m), USD Constant, 2018-2033
- Table 4: BRAF Tests Market, India, Revenue ($m), USD Constant, 2018-2033
- Table 5: BRCA Tests Market, India, Revenue ($m), USD Constant, 2018-2033
- Table 6: Colorectal Cancer Screening Tests Market, India, Revenue ($m), USD Constant, 2018-2033
- Table 7: EGFR Tests Market, India, Revenue ($m), USD Constant, 2018-2033
- Table 8: HER2 Tests Market, India, Revenue ($m), USD Constant, 2018-2033
- Table 9: KRAS Tests Market, India, Revenue ($m), USD Constant, 2018-2033
- Table 10: Oncology Market, India, Volume (Units), 2018-2033
- Table 11: ALK Tests Market, India, Volume (Units), 2018-2033
- Table 12: BCR-ABL Tests Market, India, Volume (Units), 2018-2033
- Table 13: BRAF Tests Market, India, Volume (Units), 2018-2033
- Table 14: BRCA Tests Market, India, Volume (Units), 2018-2033
- Table 15: Colorectal Cancer Screening Tests Market, India, Volume (Units), 2018-2033
- Table 16: EGFR Tests Market, India, Volume (Units), 2018-2033
- Table 17: HER2 Tests Market, India, Volume (Units), 2018-2033
- Table 18: KRAS Tests Market, India, Volume (Units), 2018-2033
- Table 19: Oncology Market, India, Average Price ($), 2018-2033
- Table 20: Oncology Market, India, Company Share by Revenue ($m), 2024
- Table 21: Oncology Market Pipeline Products
- Table 22: Oncare Secures USD1 Million in Seed Funding
- Table 23: Cambrian Bioworks Secures USD1.45 Million in Seed Financing
- Table 24: 4baseCare Raises USD5.95 Million in Series A Funding
- Table 25: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
- List of Figures
- Figure 1: Oncology Market, India, Revenue ($m), USD Constant, 2018-2033
- Figure 2: ALK Tests Market, India, Revenue ($m), USD Constant, 2018-2033
- Figure 3: BCR-ABL Tests Market, India, Revenue ($m), USD Constant, 2018-2033
- Figure 4: BRAF Tests Market, India, Revenue ($m), USD Constant, 2018-2033
- Figure 5: BRCA Tests Market, India, Revenue ($m), USD Constant, 2018-2033
- Figure 6: Colorectal Cancer Screening Tests Market, India, Revenue ($m), USD Constant, 2018-2033
- Figure 7: EGFR Tests Market, India, Revenue ($m), USD Constant, 2018-2033
- Figure 8: HER2 Tests Market, India, Revenue ($m), USD Constant, 2018-2033
- Figure 9: KRAS Tests Market, India, Revenue ($m), USD Constant, 2018-2033
- Figure 10: Oncology Market, India, Volume (Units), 2018-2033
- Figure 11: ALK Tests Market, India, Volume (Units), 2018-2033
- Figure 12: BCR-ABL Tests Market, India, Volume (Units), 2018-2033
- Figure 13: BRAF Tests Market, India, Volume (Units), 2018-2033
- Figure 14: BRCA Tests Market, India, Volume (Units), 2018-2033
- Figure 15: Colorectal Cancer Screening Tests Market, India, Volume (Units), 2018-2033
- Figure 16: EGFR Tests Market, India, Volume (Units), 2018-2033
- Figure 17: HER2 Tests Market, India, Volume (Units), 2018-2033
- Figure 18: KRAS Tests Market, India, Volume (Units), 2018-2033
- Figure 19: Oncology Market, India, Company Share (%), 2024
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook